Related Experiment Video
Updated: Jun 25, 2026
08:35
Demonstration of the Rat Ischemic Skin Wound Model
Published on: April 1, 2015
22.9K
Compromised Wound Healing in Ischemic Type 2 Diabetic Rats
Peilang Yang1, Qing Pei1, Tianyi Yu1
1Department of Burn and Plastic Surgery, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai 200025, China.
Plos One
|March 31, 2016
Summary
This study developed a type 2 diabetes rat model to investigate diabetic wound healing. The model showed impaired healing in ischemic wounds, highlighting its suitability for studying chronic diabetic wound repair.
Area of Science:
- Endocrinology
- Wound Healing Research
- Diabetology
Background:
- Ischemia significantly impairs diabetic chronic wound healing.
- Understanding the mechanisms behind diabetic wound complications is crucial.
Purpose of the Study:
- To establish a type 2 diabetes rat model.
- To investigate the impact of ischemia on diabetic wound healing.
Main Methods:
- Type 2 diabetes induced via high-fat diet and streptozotocin in rats.
- Bipedicle flap model created for ischemic wound induction.
- Histological, immunohistochemical, PCR, and immunoblot analyses performed.
Main Results:
- The model successfully replicated type 2 diabetes with insulin resistance and hyperglycemia.
- Ischemic diabetic wounds exhibited delayed healing, increased inflammation, ROS, and MMPs.
- Non-ischemic diabetic wounds showed comparatively better healing.
Conclusions:
- High-fat diet and streptozotocin effectively induce type 2 diabetes in rats.
- The ischemic diabetic wound model is suitable for studying diabetic chronic wound repair.
- Ischemia exacerbates poor healing in diabetic wounds.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...